ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.498,38
0,32%
S&P 500
5.188,16
0,01%
Dow Jones
39.052,81
0,43%
Euro vs US Dollar
1,07446
-0,05%
Bitcoin
62.038,48
-0,47%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. EXACT Sciences Corporation (EXAS)

  7. EXACT Sciences Corporation (EXAS) News

EXAS

EXACT Sciences (EXAS)

EXACT Sciences Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:EXAS
DatumZeitQuelleÜberschriftSymbolFirma
08/05/202414h29IH Market NewsU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices FallNASDAQ:EXASEXACT Sciences Corporation
07/05/202414h00Business WireExact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024NASDAQ:EXASEXACT Sciences Corporation
01/05/202412h00Business WireExact Sciences to Participate in May Investor ConferenceNASDAQ:EXASEXACT Sciences Corporation
15/04/202412h00Business WireExact Sciences Names Aaron Bloomer as New Chief Financial OfficerNASDAQ:EXASEXACT Sciences Corporation
11/04/202412h00Business WireExact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior NotesNASDAQ:EXASEXACT Sciences Corporation
08/04/202418h05Business WireExact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024NASDAQ:EXASEXACT Sciences Corporation
08/04/202412h00Business WireExact Sciences Schedules First Quarter 2024 Earnings CallNASDAQ:EXASEXACT Sciences Corporation
04/04/202412h05Business WireExact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform TreatmentNASDAQ:EXASEXACT Sciences Corporation
28/03/202411h00Business WireExact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-CancerNASDAQ:EXASEXACT Sciences Corporation
27/03/202413h05Business WireExact Sciences Named 2024 Gallup Exceptional Workplace Award WinnerNASDAQ:EXASEXACT Sciences Corporation
13/03/202422h03Business WireThe New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C StudyNASDAQ:EXASEXACT Sciences Corporation
07/03/202413h59Business WireExact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon CancerNASDAQ:EXASEXACT Sciences Corporation
05/03/202402h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
05/03/202402h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
05/03/202402h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
05/03/202402h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
05/03/202402h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
05/03/202402h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
05/03/202402h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
05/03/202402h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
05/03/202402h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/03/202421h53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/03/202421h51Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/03/202421h33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/03/202421h33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/03/202421h28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/03/202421h23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/03/202421h22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/03/202419h47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/03/202417h10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
 Showing the most relevant articles for your search:NASDAQ:EXAS

Kürzlich von Ihnen besucht

FX
EURGBP
Euro vs Sterling
TG
MBG
MercedesBenz
NYSE
JPM
JP Morgan Chase
TG
BAYN
Bayer
NASDAQ
GOOGL
Alphabet
TG
432
Arbor Metals
TG
DBK
Deutsche Bank
DBI
DAX
DAX
NASDAQ
AAPL
Apple
TG
DTE
Deutsche Telekom
CCOM
US100
US Tech 100
NYSE
DIS
Walt Disney
NASDAQ
NVDA
NVIDIA
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten